An Exploratory Study of Ixabepilone Administered as an Enteric Coated Formulation in Patients With Advanced Cancer
Phase of Trial: Phase I/II
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Ixabepilone (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 02 Nov 2007 Status change from in progress to completed.
- 21 Nov 2006 New trial record.